FDA says it is deploying AI internally to handle repetitive review tasks, alongside new guidance aimed at reliable AI evidence in approvals in reviews and filings.
AI will generate millions of jobs by 2025 while automating repetitive work, enabling industries like healthcare and finance to innovate and focus on creativity, experts say.